Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

Risk factors of recurrence in small-sized, node negative breast cancer in young women: a retrospective study in Chinese population.

Zhang X, Li P, Ma W, Di W, Zhao S, Gao Q, Zhao Y, Yang M, Zhang Q.

Sci China Life Sci. 2013 Apr;56(4):335-40. doi: 10.1007/s11427-013-4435-y. Epub 2013 Mar 12.

PMID:
23483340
2.

High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.

Gonzalez-Angulo AM, Litton JK, Broglio KR, Meric-Bernstam F, Rakkhit R, Cardoso F, Peintinger F, Hanrahan EO, Sahin A, Guray M, Larsimont D, Feoli F, Stranzl H, Buchholz TA, Valero V, Theriault R, Piccart-Gebhart M, Ravdin PM, Berry DA, Hortobagyi GN.

J Clin Oncol. 2009 Dec 1;27(34):5700-6. doi: 10.1200/JCO.2009.23.2025. Epub 2009 Nov 2.

3.

The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer.

Gabos Z, Thoms J, Ghosh S, Hanson J, Deschênes J, Sabri S, Abdulkarim B.

Breast Cancer Res Treat. 2010 Nov;124(1):187-94. doi: 10.1007/s10549-010-1135-1. Epub 2010 Sep 3.

PMID:
20814819
4.
5.

The role of immunohistochemistry in breast cancer patients treated with neoadjuvant chemotherapy: an old tool with an enduring prognostic value.

Sánchez-Muñoz A, Plata-Fernández YM, Fernández M, Jaén-Morago A, Fernández-Navarro M, de la Torre-Cabrera C, Ramirez-Tortosa C, Lomas-Garrido M, Llácer C, Navarro-Perez V, Alba-Conejo E, Sánchez-Rovira P.

Clin Breast Cancer. 2013 Apr;13(2):146-52. doi: 10.1016/j.clbc.2012.11.006. Epub 2013 Jan 11.

PMID:
23318089
6.

Is conservative surgery a good option for patients with "triple negative" breast cancer?

Martinez-Ramos D, Escrig-Sos J, Torrella-Ramos A, Alcalde-Sanchez M, Salvador-Sanchis JL.

Breast. 2012 Jun;21(3):401-5. doi: 10.1016/j.breast.2012.04.005. Epub 2012 May 11.

PMID:
22579462
7.

Different prognostic significance of Ki-67 change between pre- and post-neoadjuvant chemotherapy in various subtypes of breast cancer.

Matsubara N, Mukai H, Fujii S, Wada N.

Breast Cancer Res Treat. 2013 Jan;137(1):203-12. doi: 10.1007/s10549-012-2344-6. Epub 2012 Nov 27.

PMID:
23184081
8.

Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and pathologic tumor characteristics on breast cancer survival in Caucasian women.

Ferguson NL, Bell J, Heidel R, Lee S, Vanmeter S, Duncan L, Munsey B, Panella T, Orucevic A.

Breast J. 2013 Jan-Feb;19(1):22-30. doi: 10.1111/tbj.12059. Epub 2012 Dec 13.

PMID:
23240985
9.

Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study.

Schwentner L, Wolters R, Koretz K, Wischnewsky MB, Kreienberg R, Rottscholl R, Wöckel A.

Breast Cancer Res Treat. 2012 Apr;132(3):1073-80. doi: 10.1007/s10549-011-1935-y. Epub 2011 Dec 29.

PMID:
22205141
10.

Clinical and pathologic risk factors of tumor recurrence in patients with node-negative early breast cancer after mastectomy.

Lin PH, Yeh MH, Liu LC, Chen CJ, Tsui YC, Su CH, Wang HC, Liang JA, Chang HW, Wu HS, Yeh SP, Li LY, Chiu CF.

J Surg Oncol. 2013 Nov;108(6):352-7. doi: 10.1002/jso.23403. Epub 2013 Aug 31.

PMID:
23996583
11.

Analysis in early stage triple-negative breast cancer treated with mastectomy without adjuvant radiotherapy: patterns of failure and prognostic factors.

Chen X, Yu X, Chen J, Zhang Z, Tuan J, Shao Z, Guo X, Feng Y.

Cancer. 2013 Jul 1;119(13):2366-74. doi: 10.1002/cncr.28085. Epub 2013 Apr 10.

12.

Recurrence risk in small, node-negative, early breast cancer: a multicenter retrospective analysis.

Gamucci T, Vaccaro A, Ciancola F, Pizzuti L, Sperduti I, Moscetti L, Longo F, Fabbri MA, Giampaolo MA, Mentuccia L, Di Lauro L, Vici P.

J Cancer Res Clin Oncol. 2013 May;139(5):853-60. doi: 10.1007/s00432-013-1388-2. Epub 2013 Feb 15.

13.

[Prognostic value of estrogen receptor, progesterone receptor and human epidermal growth factor receptor-2 in node positive breast cancer patients treated by mastectomy].

Wang SL, Li YX, Song YW, Wang WH, Jin J, Liu YP, Liu XF, Yu ZH.

Zhonghua Zhong Liu Za Zhi. 2010 Jul;32(7):520-5. Chinese.

PMID:
21029696
14.

Breast cancer in young women: prognostic factors and clinicopathological features.

Aryandono T, Harijadi, Soeripto.

Asian Pac J Cancer Prev. 2006 Jul-Sep;7(3):451-4.

15.

Her-2 prognostic value in very early-stage breast cancer: a single-institution retrospective analysis.

Sanpaolo P, Barbieri V, Pedicini P, Fusco V.

Med Oncol. 2012 Jun;29(2):459-65. doi: 10.1007/s12032-011-9869-0. Epub 2011 Feb 26.

PMID:
21359639
16.

Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients.

Yin WJ, Lu JS, Di GH, Lin YP, Zhou LH, Liu GY, Wu J, Shen KW, Han QX, Shen ZZ, Shao ZM.

Breast Cancer Res Treat. 2009 May;115(2):325-33. doi: 10.1007/s10549-008-0096-0. Epub 2008 Jun 18.

PMID:
18563552
17.

Outcome of pure mucinous breast carcinoma compared to infiltrating ductal carcinoma: a population-based study from China.

Cao AY, He M, Liu ZB, Di GH, Wu J, Lu JS, Liu GY, Shen ZZ, Shao ZM.

Ann Surg Oncol. 2012 Sep;19(9):3019-27. doi: 10.1245/s10434-012-2322-6. Epub 2012 Mar 27.

PMID:
22451233
18.

[Treatment outcomes and clinicopathologic characteristics of advanced triple-negative breast cancer patients].

Zhang P, Xu BH, Ma F, Li Q, Yuan P, Wang JY, Zhang P.

Zhonghua Zhong Liu Za Zhi. 2011 May;33(5):381-4. Chinese.

PMID:
21875471
19.

The negative effect of triple-negative breast cancer on outcome after breast-conserving therapy.

Zaky SS, Lund M, May KA, Godette KD, Beitler JJ, Holmes LR, O'Regan RM, Yu ES, Yu DS, Landry JC.

Ann Surg Oncol. 2011 Oct;18(10):2858-65. doi: 10.1245/s10434-011-1669-4. Epub 2011 Mar 26.

PMID:
21442346
20.

Molecular subtype can predict the response and outcome of Chinese locally advanced breast cancer patients treated with preoperative therapy.

Chen XS, Wu JY, Huang O, Chen CM, Wu J, Lu JS, Shao ZM, Shen ZZ, Shen KW.

Oncol Rep. 2010 May;23(5):1213-20.

PMID:
20372832
Items per page

Supplemental Content

Write to the Help Desk